INTENSITY THERAPEUTICS, INC. (INTS) - Dilution Analysis

10-K filing | 2.5M shares outstanding

10-Q filing | 60.1M shares outstanding

8-K filing: Intensity Therapeutics, Inc. agreed to issue and sell 5,000,000 shares of common stock to an institutional investor at a price of $0.80 per share, for aggregate gross proceeds of $4.0 million in a registered direct offering. ($4.0M proceeds)

10-Q filing | 47.1M shares outstanding

8-K filing: Intensity Therapeutics, Inc. completed an offering of 7,676,250 shares of common stock at a price of $0.30 per share, resulting in net proceeds of approximately $1.9 million, and issued warrants to the underwriter to purchase up to 383,812 shares of common stock at an exercise price of $0.375 per share. ($0.0M proceeds)

10-Q filing | 18.4M shares outstanding

8-K filing: Intensity Therapeutics, Inc. commenced a best efforts public offering of 3,133,333 shares of common stock along with warrants to purchase up to 6,266,666 shares of common stock, with a combined offering price of $0.75 per share and accompanying warrants. ($2.35M proceeds)

S-1/A filing: The company is offering up to 2,307,692 shares of common stock and accompanying warrants, or pre-funded warrants and accompanying warrants, on a reasonable best efforts basis. The company estimates net proceeds of approximately $2.5 million assuming all securities are sold at $1.30 per share and accompanying warrants.

S-1 filing: This is an S-1 filing for a common stock offering with accompanying warrants. The company intends to use the net proceeds from the sale of the securities under this prospectus supplement for the enrollment of patients and to reach data read out in the INVINCIBLE-4 Study (expected in the first half of 2026), for the treatment of existing patients enrolled in the INVINCIBLE-3 Study (including the supply of drug product, maintenance of the study's database, and the continued safety monitoring and pharmacovigilance in the study), and for working capital and general corporate purposes.

10-K filing | 13.9M shares outstanding

S-1 filing: This S-1 filing registers up to 1,237,113 shares of common stock that may be offered by a selling stockholder.

8-K filing: Intensity Therapeutics, Inc. entered into a Securities Purchase Agreement with a healthcare focused institutional investor to issue and sell 1,237,113 shares of common stock at $2.425 per share, for gross proceeds of approximately $3.0 million in a registered direct offering, and also agreed to issue common stock warrants to purchase up to 1,237,113 shares at an exercise price of $2.95 per share in a concurrent private placement. ($3.0M proceeds)

10-Q filing | 13.8M shares outstanding

10-Q filing | 13.7M shares outstanding

S-3 filing: This is an S-3 filing for the resale of up to 394,500 shares of common stock by selling stockholders.

S-3 filing: Intensity Therapeutics, Inc. intends to offer up to $150,000,000 of any combination of common stock, preferred stock, debt securities, warrants, or units from time to time.

10-Q filing | 13.7M shares outstanding

10-K filing | 13.7M shares outstanding

10-Q filing | 13.7M shares outstanding

10-Q filing | 13.7M shares outstanding

8-K filing: Intensity Therapeutics, Inc. announces the full exercise of the underwriter's option to purchase 585,000 additional shares of common stock at $5.00 per share, resulting in gross proceeds of $2,925,000. ($2.93M proceeds)

8-K filing: Intensity Therapeutics, Inc. completed a public offering of 3,900,000 shares of common stock at $5.00 per share, resulting in gross proceeds of $19,500,000 and net proceeds of approximately $16.2 million after deducting underwriting commissions, discounts, and offering expenses. ($19.5M proceeds)

S-1/A filing: This is an S-1/A filing for the registration of the proposed offer and sale of common stock and underwriter warrants, with a proposed maximum aggregate offering price of $18,687,500 and $1,569,750 respectively.

S-1/A filing: The filing is an S-1/A for an initial public offering of 3,250,000 shares of common stock with an expected price between $4.00 and $5.00 per share.

S-1/A filing: The company is offering 3,250,000 shares of common stock in its initial public offering, with an expected price between $4.00 and $5.00 per share. Certain existing stockholders have indicated an interest in purchasing up to $1,850,000 of common stock in this offering.

S-1/A filing: This is an S-1/A filing for an initial public offering of 3,250,000 shares of common stock, with an expected price between $4.00 and $5.00 per share. Certain existing stockholders have indicated an interest in purchasing up to $1,850,000 of common stock in this offering.

S-1/A filing: This is an initial public offering of 1,777,778 shares of common stock at an expected price of $4.50 per share. Certain existing stockholders have indicated an interest in purchasing an aggregate of up to $2,500,000 of Common Stock in this offering at the initial public offering price.

S-1/A filing: The company is offering 1,777,778 shares of common stock in an initial public offering with an expected price between $4.00 and $5.00 per share.

S-1/A filing: This S-1/A filing describes an initial public offering of 2,222,223 shares of common stock with an expected price between $4.00 and $5.00 per share. Certain existing stockholders have indicated an interest in purchasing up to $5,000,000 of common stock in this offering.

S-1/A filing: Initial public offering of 2,222,223 shares of common stock with an expected price between $4.00 and $5.00 per share.

S-1/A filing: The filing is an S-1/A for an initial public offering of 2,222,223 shares of common stock with an expected price between $4.00 and $5.00 per share.

S-1/A filing: This S-1/A filing discusses an option granted to underwriters to purchase additional shares of Common Stock and/or Warrants.

S-1/A filing: This S-1/A filing describes an option granted to underwriters, exercisable for 45 days, to purchase additional shares of Common Stock and/or Warrants to purchase shares of Common Stock.

S-1/A filing: This is an S-1/A filing for common stock with a par value of $0.0001 per share. The filing includes an estimated aggregate offering price for the purpose of calculating the registration fee.

S-1/A filing: This is an S-1/A filing for common stock with a par value of $0.0001 per share. The filing includes an estimate for calculating the registration fee and mentions the underwriters' option to purchase additional shares to cover over-allotments.

S-1/A filing: This is an S-1/A filing for common stock with a $0.0001 par value per share, estimating the registration fee according to Rule 457(o) and including potential over-allotment shares for underwriters. The filing amends the registration statement to delay its effective date until a further amendment is filed or the Commission determines its effective date.

S-1/A filing: This is an S-1/A filing for common stock with a par value of $0.0001 per share. The filing includes an estimate for calculating the registration fee and mentions an option for underwriters to purchase additional shares to cover over-allotments.

S-1/A filing: S-1/A filing for common stock.

S-1 filing: This is an S-1 filing for common stock with a par value of $0.0001 per share, including additional shares for over-allotments. The registration fee is calculated according to Rule 457(o) of the Securities Act of 1933.